osteoclast size controlled fra lif/lif-receptor signalling hypoxia
osteoclasts multinucleated haematopoietic cells resorb bone increased osteoclast activity causes osteoporosis disorder resulting low bone mass high risk fractures increased osteoclast size numbers also hallmark disorders pagets disease multiple myeloma protein c fos component ap transcription factor complex essential osteoclast differentiation show fos related protein fra controls osteoclast survival size bones fra deficient newborn mice giant osteoclasts signalling leukaemia inhibitory factor lif receptor impaired similarly newborn animals lacking lif giant osteoclasts show lif direct transcriptional target fra c jun moreover bones deficient fra lif hypoxic express increased levels hypoxia induced factor alpha hif1 alpha bcl overexpression bcl sufficient induce giant osteoclasts vivo whereas fra lif affect hif1a transcriptional modulation hif prolyl hydroxylase phd2 pathway operative placenta specific inactivation fra embryo alone cause hypoxia giant osteoclast phenotype thus placenta induced hypoxia embryogenesis leads formation giant osteoclasts young pups findings offer potential targets treatment syndromes associated increased osteoclastogenesis
